| scholarly article | Q13442814 |
| P50 | author | Markus Otto | Q67390357 |
| Johannes Kornhuber | Q17068400 | ||
| Jens Wiltfang | Q42165310 | ||
| P2093 | author name string | Kretzschmar HA | |
| Poser S | |||
| Zerr I | |||
| Steinacker P | |||
| Rüther E | |||
| Bodemer M | |||
| Aitken A | |||
| Bahn E | |||
| Baxter HC | |||
| P2860 | cites work | Diagnostic criteria for sporadic Creutzfeldt-Jakob disease | Q48934056 |
| Antibodies against the major brain isoforms of 14-3-3 protein. An antibody specific for the N-acetylated amino-terminus of a protein. | Q54649952 | ||
| S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease | Q57274052 | ||
| Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid | Q57274061 | ||
| Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease | Q57781094 | ||
| ??? | Q56882731 | ||
| Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway | Q24309598 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Novel proteinaceous infectious particles cause scrapie | Q29547678 | ||
| Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study | Q33754628 | ||
| A new variant of Creutzfeldt-Jakob disease in the UK. | Q34374893 | ||
| A cellular gene encodes scrapie PrP 27-30 protein | Q34557641 | ||
| 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 | ||
| Epidemiology of Creutzfeldt-Jakob disease | Q40730013 | ||
| Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering | Q41015587 | ||
| Association of 14-3-3 proteins with centrosomes | Q42817925 | ||
| The assay development of a molecular marker for transmissible spongiform encephalopathies. | Q45930864 | ||
| Use of cerebrospinal fluid levels of 14-3-3 in predicting neurodegeneration in confirmed BSE symptomatic cattle | Q47706321 | ||
| 14-3-3 and its possible role in co-ordinating multiple signalling pathways | Q47986680 | ||
| Purification of 14-3-3 protein and analysis of isoforms in chicken brain. | Q48087654 | ||
| Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease | Q48126727 | ||
| Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein | Q48259445 | ||
| Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. | Q48297442 | ||
| A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies | Q48480572 | ||
| Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease | Q48550821 | ||
| The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies | Q48913771 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| patient | Q181600 | ||
| P304 | page(s) | 2485-2490 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. | |
| P478 | volume | 73 |
| Q43890002 | 14-3-3 Protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease |
| Q40470095 | 14-3-3 protein detection in the cerebrospinal fluid of patients with influenza-associated encephalopathy. |
| Q44247686 | 14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. |
| Q38024792 | 14-3-3 proteins in neurological disorders. |
| Q33188355 | 14-3-3 proteins in the nervous system |
| Q37149637 | 14-3-3s are potential biomarkers for HIV-related neurodegeneration |
| Q33292512 | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo |
| Q34257239 | Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease |
| Q38551782 | Application of "Omics" Technologies for Diagnosis and Pathogenesis of Neurological Infections |
| Q40066989 | Arachidonic acid binds 14-3-3zeta, releases 14-3-3zeta from phosphorylated BAD and induces aggregation of 14-3-3zeta |
| Q37969082 | Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? |
| Q45230944 | Association of 14-3-3gamma and phosphorylated bad attenuates injury in ischemic astrocytes |
| Q37206262 | Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases |
| Q33507174 | Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death |
| Q44453828 | Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. |
| Q49076335 | Clinical and therapeutic aspects of prion disease |
| Q43815986 | Creutzfeldt-Jakob disease: case report with spinal cord involvement |
| Q38044199 | Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias. |
| Q48138272 | Detection of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease Patients Using a New Automated Capillary Western Assay. |
| Q43546837 | Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay |
| Q38314346 | Differential role of 14-3-3 family members in Xenopus development |
| Q47907381 | Downregulation of 14-3-3 Proteins in a Kainic Acid-Induced Neurotoxicity Model |
| Q34134563 | Expression of 14-3-3 protein isoforms in mouse oocytes, eggs and ovarian follicular development |
| Q38933326 | Extracellular matrix protein expression in cerebrospinal fluid from patients with tropical spastic paraparesis associated with HTLV-I and Creutzfeldt-Jakob disease |
| Q35040486 | Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants |
| Q33262623 | Human body fluid proteome analysis |
| Q46605958 | Identification of different isoforms of 14-3-3 protein family in human dermal and epidermal layers. |
| Q43850058 | Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain |
| Q43753321 | Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction |
| Q28579247 | Isoform- and subcellular fraction-specific differences in hippocampal 14-3-3 levels following experimentally evoked seizures and in human temporal lobe epilepsy |
| Q47222228 | Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex |
| Q44266506 | Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo |
| Q27489715 | Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients |
| Q34038310 | Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease |
| Q21261755 | Novel mutation of the PRNP gene of a clinical CJD case |
| Q48328192 | Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome |
| Q35373453 | Proteomic changes in the cortex membrane fraction of genetic absence epilepsy rats from Strasbourg |
| Q39767003 | Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation |
| Q28652455 | Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η |
| Q36127346 | Role of glial 14-3-3 gamma protein in autoimmune demyelination |
| Q37726133 | Selective 14-3-3γ induction quenches p-β-catenin Ser37/Bax-enhanced cell death in cerebral cortical neurons during ischemia |
| Q38469036 | Shotgun proteomic analysis of Bombyx mori brain: emphasis on regulation of behavior and development of the nervous system |
| Q35768552 | Structural basis for protein-protein interactions in the 14-3-3 protein family |
| Q35103017 | The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes |
| Q28513633 | The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes |
| Q35111100 | The biology of the post-genomic era: the proteomics |
| Q48284856 | The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease. |
| Q33822953 | Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein |
| Q47381180 | Weight loss, falls, and neuropsychiatric symptoms in a 56 year-old man. |
Search more.